P.BrowningD
Furthermore, in another meta-analysis [23], which excluded ELIXA [24] due to fact that lixisenatide is a short-acting GLP-1RA and all participants had acute coronary syndrome, GLP-1RAs were associated with significant reductions in MACE (HR 0.85, 95% CI 0.800.90), cardiovascular death (HR 0.85, 95% CI 0.780.93), stroke (HR 0.81, 95% CI 0.740.90), and myocardial infarction (HR 0.88, 95% CI 0.810.96) (Table 2)
Be honest getting through screening on a lie is how people end up in the ER
That said, gastrointestinal side effects are common with Ozempic, particularly during the initial weeks of treatment or after dose escalation
PMID: 110 BelhabibIZaghdoudiSLacCBousquetCJeanC
Speaking openly and honestly will provide them with the information necessary to accurately assess your eligibility, rule out potential contradictions that could make certain medications risky, and set realistic goals